Michael Steinert Selected Research

Legionnaires' Disease (Legionnaire's Disease)

1/2021	Zinc metalloprotease ProA of Legionella pneumophila increases alveolar septal thickness in human lung tissue explants by collagen IV degradation.
10/2020	Characterization of Legionella pneumophila Populations by Multilocus Variable Number of Tandem Repeats (MLVA) Genotyping from Drinking Water and Biofilm in Hospitals from Different Regions of the West Bank.
1/2018	Acanthamoeba and Dictyostelium as Cellular Models for Legionella Infection.
11/2014	Polyketide synthase (PKS) reduces fusion of Legionella pneumophila-containing vacuoles with lysosomes and contributes to bacterial competitiveness during infection.
1/2013	Enrichment of outer membrane vesicles shed by Legionella pneumophila.
1/2011	Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein.
6/2010	Phospholipase PlaB is a new virulence factor of Legionella pneumophila.
5/2008	Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles.
3/2008	Solution structure of the Legionella pneumophila Mip-rapamycin complex.
8/2003	Biochemical and functional analyses of the Mip protein: influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Steinert Research Topics

Disease

18	Infections 02/2020 - 08/2003
10	Legionnaires' Disease (Legionnaire's Disease) 01/2021 - 08/2003
3	Diarrhea 01/2019 - 01/2016
3	Pneumonia (Pneumonitis) 01/2018 - 11/2007
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 01/2016
1	Starvation 01/2011

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2006
4	Virulence Factors (Pathogenicity Factors)IBA 02/2011 - 08/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2016
2	Streptococcus pneumoniae plY proteinIBA 01/2022 - 02/2012
2	AerosolsIBA 01/2018 - 11/2007
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2015 - 08/2003
2	EnzymesIBA 11/2009 - 05/2008
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	ZincIBA 01/2021
1	Drinking WaterIBA 10/2020
1	Peptides (Polypeptides)IBA 02/2020
1	AntibodiesIBA 10/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019
1	cis-trans-IsomerasesIBA 01/2019
1	Dextrans (Dextran)FDA Link 01/2017
1	IronIBA 01/2017
1	CollagenIBA 09/2016
1	Metronidazole (Metric)FDA LinkGeneric 01/2016
1	Vancomycin FDA LinkGeneric 01/2016
1	FidaxomicinIBA 01/2016
1	Biological ProductsIBA 11/2014
1	Polyketide SynthasesIBA 11/2014
1	Indicators and Reagents (Reagents)IBA 01/2011
1	NitrogenIBA 01/2011
1	Lysophospholipase (Phospholipase B)IBA 06/2010
1	Phospholipases (Phospholipase)IBA 06/2010
1	Cysteine Proteinase InhibitorsIBA 11/2009
1	Antimicrobial PeptidesIBA 10/2009
1	Tacrolimus Binding Protein 1A (FKBP12)IBA 03/2008
1	Pharmaceutical PreparationsIBA 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 03/2006
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2006
1	Lysosomal Membrane ProteinsIBA 01/2006

Therapy/Procedure

1	Fecal Microbiota Transplantation 01/2016
1	Length of Stay 01/2016